Skip to main content
SpringerLink
Log in

Management of Cervical Dysplasia

  • Living reference work entry
  • First Online:
Handbook of Gynecology

  • 234 Accesses

Abstract

Abnormal cervical screening tests are diagnosed in millions of women each year in the United States. In some, the abnormality is indicative of cervical dysplasia or even invasive cervical cancer. The work-up of an abnormal cervical screening test includes colposcopy and cervical biopsies. Based on those results, treatment for cervical dysplasia can consist of observation or intervention with an excisional biopsy. In deciding to intervene aggressively, one must consider special circumstances including patient age, desire for future fertility, and concurrent pregnancy. Understanding the role human papillomavirus (HPV) plays in cancer development has led to advancements in detection and treatment of cervical dysplasia. Both preventative and therapeutic vaccinations against HPV provide promise in decreasing the number of women affected by this disease. This chapter highlights key changes in the recent ASCCP guidelines including the importance of conservative management among younger women as well as recommendations on the proper utilization of HPV cotesting. The rationale for HPV vaccination is also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • ACOG. Practice Bulletin Number 140: management of abnormal cervical cancer screening test results and cervical cancer precursors. Obstet Gynecol. 2013;122(6):1338–67.

    Article  Google Scholar 

  • ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003;90:366–371.

    Google Scholar 

  • Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the United States: a 35-year population based analysis. J Women’s Health. 2012;21(10):1031–7.

    Article  Google Scholar 

  • Arbyn M, Bergeron C, et al. Liquid compared with conventional cervical cytology: a systemic review and meta-analysis. Obstet Gynecol. 2008;111(1):167–77.

    Article  PubMed  Google Scholar 

  • ASCCP: http://www.asccp.org/Guidelines

  • Baggish MS. Colposcopy of the cervix, vagina and vulva: a comprehensive textbook. Philadelphia: Mosby; 2003. p. 79–97.

    Google Scholar 

  • Baldur-Felskov B, Dehlendorff C, Munk C, Kjaer SK. Early impact of human papillomavirus vaccination on cervical neoplasia: nationwide follow-up of Young Danish women. JNCI J Natl Cancer Inst. 2014;106(3):djt460.

    Article  PubMed  Google Scholar 

  • de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048–56.

    Article  PubMed  Google Scholar 

  • Erickson BK, Alvarez RD, Huh WK. Human papillomavirus: what every provider should know. Am J Obstet Gynecol. 2013;208(3):169–75.

    Article  PubMed  Google Scholar 

  • Fader AN, Alward EK, Niederhauser A, et al. Cervical dysplasia in pregnancy: a multi-institutional evaluation. Am J Obstet Gynecol. 2010;203:113.e1–6.

    Article  Google Scholar 

  • Frey HA, Conner SN. Treatment of cervical dysplasia and the risk of preterm birth: understanding the association. Am J Obstet Gynecol. 2015;213(4):445–6.

    Article  PubMed  Google Scholar 

  • Grimm C, Polterauer S, Natter C, et al. Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial. Obstet Gynecol. 2012;120:152–9.

    Article  CAS  PubMed  Google Scholar 

  • Huang LW, Hwang JL. A comparison between loop electrosurgical excision procedure and cold knife conization for treatment of cervical dysplasia: residual disease in a subsequent hysterectomy specimen. Gynecol Oncol. 1999;73(1):12–5.

    Article  CAS  PubMed  Google Scholar 

  • Huh W, Sideri M, et al. Relevance of random biopsy at the transformation zone when colposcopy is negative. Obstet Gynecol. 2014;124(4):670–8.

    Article  PubMed  Google Scholar 

  • Insinga RP, Glass AG, Rush BB. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol. 2004;191:105–13.

    Article  PubMed  Google Scholar 

  • Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372:711–23.

    Article  CAS  PubMed  Google Scholar 

  • Kobak WH, Roman LD, et al. The role of endocervical curettage at cervical conization for high-grade dysplasia. Obstet Gynecol. 1996;85:197–201.

    Article  Google Scholar 

  • Mahmud SM, Kliewer EV, Lambert P, Bozat-Emre S, Demers AA. Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada. J Clin Oncol. 2014;32:438–43.

    Article  PubMed  Google Scholar 

  • Merck: www.merckvaccines.com/products/gardasil

  • Morrow CP, Sideri M. Surgery for cervical neoplasia. In: Gynecologic cancer surgery. Encinitas: South Coast Medical Publishing; 2013. p. 513–33.

    Google Scholar 

  • Nanda K, McCrory DC, et al. Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systemic review. Ann Intern Med. 2000;132:810–9.

    Article  CAS  PubMed  Google Scholar 

  • Nguyen ML, Flowers L. Cervical cancer screening in immunocompromised women. Obstet Gynecol Clin N Am. 2013;40(2):339–57.

    Article  Google Scholar 

  • Nooh AM, Mohamed ME, El-Alfy Y. Visual inspection of cervix with acetic acid as a screening modality for cervical cancer. J Low Genit Tract Dis. 2015;19:340–4.

    Article  PubMed  Google Scholar 

  • Rahangdale L, Lippmann OK, Garcia K, et al. Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial. Am J Obstet Gynecol. 2014;210:314.e1–8.

    Article  CAS  Google Scholar 

  • Robboy SJ, Anderson MC, Russel P. Pathology of the female reproductive tract. Philadelphia: Churchill Livingstone; 2002. p. 165–93.

    Google Scholar 

  • Seer database: http://seer.cancer.gov/statfacts/html/cervix.html

  • Solomon D, Darvy D, Kurman R, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114–9.

    Article  PubMed  Google Scholar 

  • Tierney KE, Lin PS, Amezcua C, et al. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. Am J Obstet Gynecol. 2014;210:366.e1–5.

    Article  Google Scholar 

  • Trimble CL, Morrow MP, Kraynyak KA, et al. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomized, double-blind, placebo-controlled phase 2b trial. Lancet. 2015;386:2078. Published online.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wheeler CM. The natural history of cervical human papillomavirus infection and cervical cancer: gaps in knowledge and future horizons. Obstet Gynecol Clin N Am. 2013;40:165–76.

    Article  Google Scholar 

  • Wright TC Jr, Massad LS, et al. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis. 2007;11(4):201–22.

    Article  PubMed  Google Scholar 

  • Wright TC. Pathogenesis and diagnosis of preinvasive lesions of the lower genital tract. In: Principles and practice of gynecologic oncology. Philadelphia: Lippincott/Williams and Wilkins; 2009.

    Google Scholar 

  • Wright TC, Stoler MH, et al. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. 2012;206:46.e8–11.

    Article  Google Scholar 

  • Zhao C, et al. Human papillomavirus testing and reporting rates in 2012: results of a College of American Pathologists National Survey. Arch Pathol Lab Med. 2015;139:756–61.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Kaiser Permanente Orange County, California, Irvine, CA, USA

    Katherine E. Tierney

  2. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA

    Lynda D. Roman & Koji Matsuo

Authors
  1. Katherine E. Tierney
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lynda D. Roman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Koji Matsuo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Katherine E. Tierney , Lynda D. Roman or Koji Matsuo .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology and Family Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA

    Donna Shoupe

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing AG

About this entry

Cite this entry

Tierney, K.E., Roman, L.D., Matsuo, K. (2016). Management of Cervical Dysplasia. In: Shoupe, D. (eds) Handbook of Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-17002-2_7-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17002-2_7-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Online ISBN: 978-3-319-17002-2

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation